This site is intended for healthcare professionals
News

PENELOPE-B trial of Ibrance in early breast cancer did not meet primary endpoint- Pfizer

Read time: 1 mins
Last updated:12th Oct 2020
Published:11th Oct 2020
Condition: Breast Cancer HER2+
Type: drug
Register free for full access to medthority.com